Kyma Medical technologies had to make a critical decision: we had a few options for products which we could design based on our core technology, with very different profiles with respect to time to market, regulatory pathway, reimbursement, IP, ROI and other considerations. We used consultants in each field but needed an expert to integrate the various inputs and help us make a meaningful informed decision. BioMarketing came through for us with a detailed business analysis, supported by clear financial models which made the right solution stand out. With this analysis we were able to convince our board of directors, which in turn has committed to to further invest in the company.

- Assaf Bernstein, CEO